|
⚲
|
| Keyboard |
| Dravite Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002133272 |
| Sale | 2026-04-20 (15.0 M Offered, 15.0 M Sold) |
| Fund | |
| Phone | 6502693210 |
| Address | 401 Cambridge Street San Francisco, CA 94134 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-06-24 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Michael Moore | Executive Officer | |
| Barbara Kosacz | Director | |
| Sandeep Kulkarni | Director | |
| Joseph Sum | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
Institutional Venture Management XVII LLC
✚
|
CA | |
|
The Social Capital Partnership LLC
✚
|
CA | |
|
Otherwise Fund Management LLC
✚
|
CA | |
|
Bullpen Management LLC
✚
|
CA | |
|
Type One Management LLC
✚
|
CA | |
|
Hanabi Capital Management LLC
✚
|
CA | |
|
Liquid 2 Ventures LLC
✚
|
CA | |
|
Canvas Management Company LLC
✚
|
CA | |
|
Good Friends LLC
✚
|
CA | |
|
MNS Global Capital Managers LLC
✚
|
CA |